20Slash20 Inc., the creator of The Eye Drink, announced it will participate in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, scheduled for Sept. 9–10, 2026, in New York City. The company's CEO, Dr. Roger Wu, is set to deliver an investor presentation on Sept. 9 at 9:35 a.m. ET at The Westin New York Grand Central. Following the presentation, Dr. Wu will hold one-on-one meetings with investors, providing an opportunity to discuss the company's vision and progress.
The conference is designed to bring together growth companies, investors, and industry professionals across life sciences and other emerging sectors. For 20Slash20, this event serves as a platform to showcase its flagship product, The Eye Drink, which the company describes as the world's first ready-to-drink functional beverage formulated specifically for individuals who spend extended hours on digital devices. The beverage incorporates science-backed ingredients to support eye health, addressing the growing concern of screen-induced eye problems.
The announcement comes at a time when digital device usage is at an all-time high, with many people relying on phones and computers for work and leisure. According to recent studies, prolonged screen time can lead to symptoms such as eye strain, dryness, and blurred vision, collectively known as computer vision syndrome. The Eye Drink aims to offer a convenient and tasty solution to support eye health in this context.
Dr. Roger Wu, CEO of 20Slash20, emphasized the importance of the conference as a venue to connect with potential investors and partners. "We are excited to present at the Moody Capital Solutions Conference and share our mission of promoting eye health through innovative nutrition," Wu said. "This is an opportunity to highlight the science behind The Eye Drink and its potential to make a meaningful impact on the daily lives of millions."
The conference will also feature presentations from other companies in the life sciences and disruptive growth sectors, offering a diverse range of investment opportunities. For 20Slash20, participation aligns with its strategic efforts to increase visibility and attract investment to scale its operations and expand market reach.
The Eye Drink is positioned in the rapidly growing functional beverage market, which has seen increased consumer interest in products that offer health benefits beyond basic nutrition. With its focus on eye health, 20Slash20 taps into a niche that is particularly relevant in the digital age. The company's participation in the conference is expected to generate interest among investors looking for innovative products with strong market potential.
For more information about the conference and 20Slash20's participation, interested parties can access the full press release at https://ibn.fm/tm2lT.
